Fluorescent photoprobe for the imaging of endothelin receptors
US8212058B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2006 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Oct 18, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a endothelin receptor antagonist conjugate of the formula (I) wherein R2 is an alkoxy group and one of R1 and R3 represents an alkoxy group and the other represents a group of the formula: (OCH2CH2)n—NH—X, wherein n is an integer of 1 to 100 and X represents a fluorescent dye and tautomers thereof. Furthermore, the present invention relates to a diagnostic composition comprising the compounds of the invention. The present invention also relates to the use of the compounds of the invention for the preparation of a diagnostic composition for the diagnosis of cancer, the evaluation of cancer biology and/or monitoring of anticancer therapy. In a further aspect, the present invention relates to kits comprising the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.